The research progress of anticoagulation of extracorporeal memebrane oxygenation in children
10.3760/cma.j.issn.1673-4912.2021.03.011
- VernacularTitle:儿童体外膜肺氧合抗凝研究进展
- Author:
Baowang YANG
;
Xiaoyang HONG
;
Zhichun FENG
- From:
Chinese Pediatric Emergency Medicine
2021;28(3):215-219
- CountryChina
- Language:Chinese
-
Abstract:
Extracorporeal membrane oxygenation(ECMO)is more and more widely used in children as a supporting technology for cardiopulmonary organ failure, but bleeding and thrombus are still the most common and serious complications during the use of ECMO.Heparin is the most commonly used anticoagulant in children with ECMO.Activated clotting time, activated partial thromboplastin time, and anti-Ⅹa activity are often monitored to guide the dosage of heparin.However, the optimal dosage of heparin and the appropriate monitoring method are still unclear.This study aimed to summarize the research progress of anticoagulation and monitoring methods in children′s ECMO.
